Compare Goldman Sachs Group Inc (GS) vs Herbalife Nutrition Ltd (HLF) Price & Performance

Goldman Sachs (GS) trades at $1,140, up 9.0% over 24 hours, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $20.98 versus $14.47, and revenue growth from $58.28B in 2025 to $60.4B projected for 2026. Recent news highlights Goldman's role in leading high-profile IPOs including Anthropic, signaling strong investment banking pipeline strength.

Outlook remains positive with analyst consensus price target of $1,140K and 40% buy ratings, though RSI levels suggest potential near-term overbought conditions. Key risks include volatile cash flow patterns and high leverage, while institutional sentiment supports continued growth from M&A activity and AI-driven market opportunities.

HLF trades at $12.45, up 1.72% today, with a bearish technical signal from moving averages. The company shows stable revenue around $5B annually, with a net income margin of 4.66% in 2025. Recent Q1 2026 earnings beat expectations, and the company raised full-year guidance. Positive news includes inclusion in TIME's America's Best Companies 2026 and a major debt refinancing, though insider selling and negative shareholder equity present concerns.

The outlook is mixed: strong brand recognition and earnings beats support upside, but high debt levels and bearish technicals pose risks. Analyst consensus is bullish with 57.7% buy ratings, yet the stock faces headwinds from competitive pressures and reliance on international growth markets like India.